New Recommendations on How to Stage Hidradenitis Suppurativa

Slides:



Advertisements
Similar presentations
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Advertisements

Moderate-to-Severe Asthma Management
Evolving Paradigms in the Management of HR-Positive Breast Cancer
Clinical Trials in IBD.
New Psoriasis Treatments
Psoriatic Arthritis.
A Review of the Critical Role of Imaging in Primary Liver Malignancy
Why Gene Therapy for Hemophilia?
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.
Unraveling Clinical Developments in NASH
Management of Mild to Moderate Asthma
T-Cell Exhaustion: Can We Overcome It in Cancer?
Advances in Managing Inhibitors in Patients With Hemophilia A
Pseudomonas Lung Infections in Cystic Fibrosis
Case Studies.
Progression After Cancer Immunotherapy in Advanced NSCLC
Understanding the Many Faces of Pseudobulbar Affect
Standards of Care in Duchenne Muscular Dystrophy: A 2018 Update
Improving Acne Outcomes
Updates in Management of Atopic Dermatitis From Real Patient Cases
Advances in Dry Eye.
Induction Chemotherapy for Patients With High-Risk or Secondary AML
Treat to Target in Gout.
Chronic Idiopathic Urticaria
Addressing Disease Burden in Asthma
Asthma and Atopic Comorbidities
Immunotherapy in Pancreatic Cancer: Thinking Outside the Box
Optimizing Management of Advanced Bladder Cancer
A Frontline Clinician's Guide to Managing Opioid-Induced Constipation
Multidisciplinary Perspectives on Interstitial Lung Diseases
The Emerging Role of Immunotherapy in Hodgkin Lymphoma
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Next-Gen Psoriasis Therapies:
Evaluating Next-Generation BTK Inhibitors
Hyperhidrosis Is Burdensome!
Gene Therapy: Past, Present, and Future
Emerging Atopic Dermatitis Treatments:
Tackling Atopic Dermatitis
Therapeutic Approaches to the Management of EDS in OSA
Immunotherapy for cSCC
Novel Approaches in T1D Management
Perspectives on the Impact of Inflammation in OA
Updates in Neurogenic Orthostatic Hypotension
EGFR-Mutated NSCLC and CNS Involvement: the Conundrum
New Data on Emerging Treatments for Psoriasis
When Is Biologic Therapy Appropriate for HS?
Parkinson Disease Psychosis
Best Clinical Pearls in Hidradenitis Suppurativa:
When to Start and What to Use
Advances in Immunotherapy for Peanut Allergy
Immune Checkpoint Inhibitors in Lung Cancer
Scientific Update.
Guide to Atopic Dermatitis
EGPA.
The Burden of Psoriasis:
Patient Questions and Expert Answers in Psoriasis:
Biomarker Testing: Harnessing All Sides of the Tumor Microenvironment
Optimizing Joint Health in Hemophilia
This program will include a discussion of off-label treatment and investigational agents not approved by the Food and Drug Administration for use in the.
Novel Concepts in the Management of RCC
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States, and data.
From Adjuvant to Metastatic in Melanoma
Immune Checkpoint Inhibitors in EGFR-Mutated NSCLC
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Optimizing Outcomes in mRCC: Finding the Balance of Immune Inhibition
This program will include a discussion of off-label treatment or use of investigational agents not approved by the FDA for use in the US, and data that.
HAE Prophylaxis.
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Immune Checkpoint Inhibitors in Lung Cancer
Foundations of Asthma.
Presentation transcript:

New Recommendations on How to Stage Hidradenitis Suppurativa

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.

Introduction to HS

Tools to Assess Disease Severity

Hurley Staging System

HS-PGA Scoring System

HiSCR Assessment

Practical Use of Assessments

Additional Testing

Long-Term Approach to Treatment

Psychosocial Burden QoL Effects

First-Step Recommendations

European Guidelines for Treatments

Treatment by Disease Severity

Concluding Remarks

Abbreviations